A MULTI-CENTER RANDOMIZED TRIAL OF BUPRENORPHINE-NALOXONE VERSUS CLONIDINE FOR OPIOID DETOXIFICATION: FINDINGS FROM THE NATIONAL INSTITUTE ON DRUG ABUSE CLINICAL TRIALS NETWORK

Eitemau Tebyg

• PREDICTORS OF OUTCOME FOR SHORT-TERM MEDICALLY SUPERVISED OPIOID WITHDRAWAL DURING A RANDOMIZED, MULTICENTER TRIAL OF BUPRENORPHINE-NALOXONE AND CLONIDINE IN THE NIDA CLINICAL TRIALS NETWORK DRUG AND ALCOHOL DEPENDENCE
  gan: ZIEDONIS, D.M
  Cyhoeddwyd: (2009)
• Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial
  gan: Hser, Y.I
  Cyhoeddwyd: (2016)
• PAIN AND CONTINUED OPIOID USE IN INDIVIDUALS RECEIVING BUPRENORPHINE-NALOXONE FOR OPIOID DETOXIFICATION: SECONDARY ANALYSES FROM THE CLINICAL TRIALS NETWORK
  gan: POTTER, J.S
  Cyhoeddwyd: (2010)
• Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
  gan: Hser, Y.I
  Cyhoeddwyd: (2014)
• A RANDOMIZED TRIAL OF EFFECTIVENESS AND COST EFFECTIVENESS OF OBSERVED VERSUS UNOBSERVED ADMINISTRATION OF BUPRENORPHINE NALOXONE FOR HEROIN DEPENDENCE
  gan: BELL, J.
  Cyhoeddwyd: (2008)